PRIMAGEN ANNOUNCES NEW CLINICAL RESEARCH SERVICES FOR ANGIOGENESIS

A A

After introducing its Cancer Biomarkers activities at the AACR in April this year, Primagen Holding BV, a molecular diagnostics company, will exhibit its products in booth #4463 at the American Society of Clinical Oncology (ASCO) meeting being held in Atlanta, Georgia, from June 2-6. The company is expanding its focus into the area of clinical oncology with new Clinical Research Services on its multiple mRNA expression markers and free-circulating mtDNA and mtRNA tests.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-24-2006/0004368145&EDATE=)